United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript May 1, 2024
United Therapeutics Corporation beats earnings expectations. Reported EPS is $6.17, expectations were $5.65. UTHR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good morning and welcome to the United Therapeutics Corporation First Quarter 2024 Earnings Webcast. My name is Danielle and I will be your conference operator today. All participants on the call portion of this webcast will be in listen-only mode until the question-and-answer portion of the earnings call. [Operator Instructions] Please note this call is being recorded. I will now turn the webcast over to Dewey Steadman, Head of Investor Relations at United Therapeutics.
Dewey Steadman: Thank you, Danielle and good morning. It’s my pleasure to welcome you to the United Therapeutics Corporation’s first quarter…
